BOSTON--(BUSINESS WIRE)--Apr. 30, 2015--
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that the company will participate at the following
upcoming investor conferences:
-
Deutsche Bank 40th Annual Healthcare Conference on Wednesday, May 6,
2015 at 3:30 p.m. ET at the InterContinental Hotel in Boston
-
Mizuho Securities USA Third Annual Healthcare Corporate Access Day on
Tuesday, May 5, 2015, the Omni Berkshire Hotel in New York City
A live audio webcast of the Deutsche Bank presentation will be available
on the company's website at www.verastem.com.
An archived presentation will be available for 90 days.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and metastasis.
Verastem is developing small molecule inhibitors of signaling pathways
that are critical to cancer stem cell survival and proliferation: FAK
and PI3K/mTOR. For more information, please visit www.verastem.com.
Source: Verastem, Inc.
Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com
